Clonazepam

Category
Anti-epileptic
Product code
1622-61-3

Clonazepam is a benzodiazepine-class active pharmaceutical ingredient widely used for the treatment of seizure disorders and panic disorder. By enhancing the effect of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system, Clonazepam reduces abnormal electrical activity in the brain, providing anticonvulsant, anxiolytic, and sedative effects. Its long duration of action makes it particularly effective in managing chronic epilepsy syndromes and anxiety conditions. Pharmaceutical companies formulate Clonazepam into oral tablets and orally disintegrating tablets, supporting flexible therapeutic use across neurological and psychiatric care.

Common Clonazepam Uses and Treated Conditions

  • Epilepsy – Effective in controlling various types of seizures, including absence, myoclonic, and akinetic seizures.
  • Lennox–Gastaut Syndrome – Used as adjunctive therapy for managing seizure activity in this severe epilepsy condition.
  • Panic Disorder – Provides relief from panic attacks and related anxiety symptoms.
  • Acute Seizure Management – Supports control of breakthrough or acute seizure episodes.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Clonazepam API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Clonazepam, visit the official CAS webpage.

If you’d like more information or to request a sample, contact our Generic API team today.

Clonazepam

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us